Wednesday, July 15, 2020 / 2:25 PM / NSE / Header Image Credit: GlaxoSmithKline
This message is to remind all, particularly GlaxoSmithKline Consumer Nigeria Plc ("GSK") and other relevant "insiders", that our Company will be in the Closed Period with effect from Tuesday, 14th July 2020.
The Board Meeting where the results will be considered will hold on Wednesday, 29th July 2020 and the result is expected to be released to the Market on or before the 30th July 2020 and the closed period will be lifted 24 hours thereafter.
During this period, Staff, Complimentary Staff and Management who have regular access to GSK financial information or results that might be material and/or price sensitive, should observe this earnings-related closed period and not buy or sell GSK shares.
This is in line with the rules of the Nigerian Stock Exchange. The rules are also spelt out in our Procedure for Dealing in Securities - GSK Corporate SOP_606739 (6.0). If you have any questions regarding this policy or the applicability of the policy to you or your activities, please email the Company Secretary at firstname.lastname@example.org
Visit GlaxoSmithKline Consumer Nigeria Plc IR Page in Proshare MARKETS
Graph - One Year Share Price Movement
Table: Q1 2020 Unaudited Results